comparemela.com

Latest Breaking News On - Katja arnold - Page 6 : comparemela.com

InflaRx N V : InflaRx Announces Closing of $40 Million Public Offering of Ordinary Shares

JENA, Germany, April 14, 2023 (GLOBE NEWSWIRE) InflaRx N.V. (Nasdaq: IFRX) (the "Company"), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement

Sankt peterburgUnited statesRegina lutzInflarx gmbKatja arnoldLaurie doyleDrug administrationLifesci capitalRaymond james associates incEuropean medicines agencyMc servicesInflarx pharmaceuticals incExchange commissionEquity syndicateRaymond jamesInflarx pharmaceuticals

InflaRx Announces Closing of $40 Million Public Offering of Ordinary Shares

JENA, Germany, April 14, 2023 InflaRx N.V. , a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, announced today that it has. | April 14, 2023

United statesSankt peterburgRegina lutzKatja arnoldInflarx gmbLaurie doyleRaymond james associates incEuropean medicines agencyLifesci capitalInflarx pharmaceuticals incGlobenewswire incExchange commissionEquity syndicateMc servicesDrug administrationSci capital

InflaRx Announces Pricing of $40 Million Public Offering of

JENA, Germany, April 12, 2023 (GLOBE NEWSWIRE) InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a clinical-stage biopharmaceutical company developing.

United statesSankt peterburgKatja arnoldRegina lutzInflarx gmbLaurie doyleMc servicesRaymond james associates incEuropean medicines agencyEquity syndicateDrug administrationInflarx pharmaceuticals incLifesci capitalExchange commissionRaymond jamesInflarx pharmaceuticals

InflaRx N V : InflaRx Announces Public Offering of Ordinary Shares

JENA, Germany, April 11, 2023 (GLOBE NEWSWIRE) InflaRx N.V. (Nasdaq: IFRX) (the "Company"), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement

United statesSankt peterburgKatja arnoldLaurie doyleRegina lutzInflarx gmbRaymond james associates incEuropean medicines agencyMc servicesEquity syndicateExchange commissionLifesci capitalInflarx pharmaceuticals incDrug administrationRaymond jamesInflarx pharmaceuticals

ONWARD to Attend Upcoming Scientific and Investor Events

EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA, April 12, 2023 ONWARD Medical N.V. , the medical technology company creating innovative therapies to restore movement,. | April 12, 2023

United statesSwitzerland generalUnited kingdomCity ofKaja skorkaKatja arnoldJohanna koblerLara smith weberLaurie doyleVaud chamberLausanne university hospitalCompany enquiriesSwiss federal institute of technologySociety for paraplegiaScientific meeting american spinal injury associationEngineering center

vimarsana © 2020. All Rights Reserved.